Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | SLC6A12 | P48065 | 3/20 | 0.39 |
| ▸ | SLC6A11 | P48066 | 3/20 | 0.39 |
| ▸ | SLC6A13 | Q9NSD5 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17934358 | 0.93 | SLC6A12 (0.45) | KDM4EALDH1A1TDP1SLC6A12SLC6A11 | |
| SCHEMBL29936790 | 0.93 | SLC6A12 (0.45) | KDM4EALDH1A1TDP1SLC6A12SLC6A11 | |
| SCHEMBL9887148 | 0.93 | SLC6A12 (0.45) | KDM4EALDH1A1TDP1SLC6A12SLC6A11 | |
| SCHEMBL560786 | 0.93 | SLC6A12 (0.45) | KDM4EALDH1A1TDP1SLC6A12SLC6A11 | |
| SCHEMBL17331216 | 0.93 | SLC6A12 (0.45) | KDM4EALDH1A1TDP1SLC6A12SLC6A11 | |
| SCHEMBL23694121 | 0.93 | SLC6A12 (0.45) | KDM4EALDH1A1TDP1SLC6A12SLC6A11 | |
| SCHEMBL1787909 | 0.93 | SLC6A12 (0.45) | KDM4EALDH1A1TDP1SLC6A12SLC6A11 | |
| SCHEMBL75258 | 0.93 | SLC6A12 (0.45) | KDM4EALDH1A1TDP1SLC6A12SLC6A11 | |
| SCHEMBL11613410 | 0.89 | SLC6A12 (0.42) | KDM4EALDH1A1TDP1SLC6A12SLC6A11 | |
| SCHEMBL1299834 | 0.80 | KDM4E (0.35) | KDM4EALDH1A1TDP1SLC6A12SLC6A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011112970-A2 | COMPOSITIONS AND METHODS FOR BIOCONJUGATION TO QUANTUM DOTS | THE GENERAL HOSPITAL CORPORATION (US) | 2011-09-15 | — | — | WO | disclosed |